Retraction Note: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12883-020-02025-3
Main Authors: | Christessa Emille Que Albay, Frederick Gavril D. Leyson, Federick C. Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | BMC Neurology |
Online Access: | https://doi.org/10.1186/s12883-020-02025-3 |
Similar Items
-
Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
by: Christessa Emille Que Albay, et al.
Published: (2020-06-01) -
Stopping “transient ischemic attacks” by antiplatelet withdrawal
by: Lina Palaiodimou, et al.
Published: (2021-04-01) -
Stroke and transient ischemic attacks related to antiplatelet or warfarin interruption
by: Vanessa RIZELIO, et al. -
Secondary Prevention of Stroke and Death by Antiplatelet Therapies in Patients with Ischemic Stroke or Transient Ischemic Attack
by: Ya-Fang Shiau, et al.
Published: (2009) -
Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
by: Cinzia Del Giovane, et al.
Published: (2021-08-01)